The trademark application CHATTR was filed by Alnylam Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on April 8, 2021, and it was registered by office on July 16, 2021 without any oppositions.
The application was filed in English (Italian was selected as the second language).